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ABSTRACT Aberrant expression of casein kinase 2 (CK2) is associated with tumor progres-
sion; however, the molecular mechanism by which CK2 modulates tumorigenesis is incom-
pletely understood. In this paper, we show that CK2α phosphorylates the C-terminal domain 
of the nuclear receptor corepressor (NCoR) at Ser-2436 to stabilize the NCoR against the 
ubiquitin-dependent proteasomal degradation pathway. Importantly, NCoR promoted the 
invasion of esophageal cancer cells in a CK2-dependent manner. By using cyclic DNA microar-
ray analysis, we identified CXCL10/IP-10 as a novel CK2α-NCoR cascade–regulated gene. The 
depletion of both NCoR and HDAC3 commonly derepressed IP-10 transcription, demonstrat-
ing the functional engagement of the NCoR-HDAC3 axis in IP-10 transcriptional repression. 
Furthermore, chromatin immunoprecipitation assays showed that c-Jun recruits NCoR-HDAC3 
corepressor complexes to the (AP1 site of IP-10, leading to histone hypoacetylation and IP-10 
down-regulation. Collectively these data suggest that the CK2α-NCoR cascade selectively 
represses the transcription of IP-10 and promotes oncogenic signaling in human esophageal 
cancer cells.
INTRODUCTION
The nuclear receptor corepressor (NCoR) and silencing mediator for 
retinoic and thyroid receptors (SMRT) are well-known corepressors 
of nuclear receptors (NRs) and many other transcription factors 
(Perissi et al., 2010). Both NCoR and SMRT form corepressor com-
plexes with histone deacetylase 3 (HDAC3) that induce changes in 
local chromatin structure, causing transcriptional repression. The N-
terminus of NCoR contains four repression domains associated with 
protein–protein interactions that mediate the formation of a core 
complex with transducin-β–like protein 1 (TBL1), the TBL1 receptor 1 
(TBLR1), G-protein pathway suppressor 2 (GPS2), and HDAC3 (Yoon 
et al., 2003a,b). The receptor interaction domain resides in the 
C-terminal half of NCoR and recognizes and binds to unliganded 
NRs (Seol et al., 1996). Accumulated studies have shown that the 
function of NCoR and SMRT in transcriptional repression is regu-
lated by posttranslational modification. The sumoylation of NCoR by 
SUMO and ubiquitin-conjugating enzyme 9 (Ubc9), an E2 conjuga-
tion enzyme, results in enhanced NCoR-dependent transcriptional 
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showed that the NRID of NCoR directly interacted with CK2α, but 
not with CK2β (Figure 1B and Supplemental Figure S1, A and B). 
Thus a specific interaction domain of NCoR with CK2α was mapped 
to the region between residues 1985 and 2440 in NCoR (NCoR-
15/16 [NRID]).
We next examined whether CK2α directly phosphorylates the 
NCoR-15/16 domain by performing in vitro kinase assays using vari-
ous GST-NCoR-15/16 domain proteins as indicated in Figure 1C. 
CK2α efficiently phosphorylated the C-terminal region of the NCoR-
15/16-3 domain (Figures 1C and S1C), suggesting that the target 
phosphorylation site of CK2α may be located within the NCoR-
15/16-3 domain. To verify the in vitro kinase assay results, we as-
sessed inhibition of NCoR phosphorylation using a specific inhibitor 
against CK2—4,5,6,7-tetrabromo-2-azabenzimidazole (TBB). As ex-
pected, TBB dose-dependently blocked CK2α-dependent NCoR 
phosphorylation in vitro (Figure S1D). To confirm CK2α-dependent 
NCoR phosphorylation in vivo, we transfected HeLa cells with the 
FLAG-tagged NCoR-15/16 expression plasmid with CK2α expres-
sion plasmids with or without TBB. The phosphoform of NCoR-
15/16 was detected by coexpression of CK2α; however, 50 μM of 
TBB completely blocked NCoR-15/16 phosphorylation with negli-
gible effect on the cytotoxicity (unpublished data), indicating that 
NCoR is phosphorylated by CK2α in vivo (Figure S1E).
CK2a phosphorylates the Ser-2436 residue of NCoR
To identify the critical amino acid for CK2α-dependent NCoR phos-
phorylation, we used the computational NetPhosK 1.0 prediction 
program. Sequence analysis predicted three phosphorylation sites 
in the NRID domain (Figure S2A). For accurate determination of the 
phosphorylation site in NCoR, we generated glutathione S-trans-
ferase (GST)-tagged mutant plasmids in which serine was substi-
tuted for alanine, and mutant plasmids were screened using in vitro 
kinase assays. Replacement with alanine of both Ser-2143 and Ser-
2144 in the NRID domain had a negligible effect on phosphoryla-
tion; however, mutation of Ser-2436 resulted in complete loss of 
phosphorylation in the NRID domain, providing evidence that the 
Ser-2436 residue of NCoR is critical for CK2α-dependent phospho-
rylation (Figure 1D).
To further examine whether NCoR Ser-2436 is phosphorylated 
by CK2α and to study the biological importance of phosphorylation 
at this site, we generated a phosphospecific NCoR antibody that 
specifically recognizes phosphorylated Ser-2436 (Ser(P)-2436) in 
NCoR. Polyclonal antibodies were generated against the NCoR 
phosphopeptide 2431CQYETLpSDSDD2440 (Figure S2B), and the an-
tisera were tested by Western blot analysis after in vitro kinase reac-
tion. Specificity of the antibodies was shown by recognition that 
NCoR-15/16WT, but not NCoR-15/16S2436A, could be phosphory-
lated at this site (Figure 1E). Furthermore, a peptide competition 
assay clearly exhibited the specificity of the NCoR Ser(P)-2436 anti-
body through complete blocking of NCoR phosphorylation by 
treatment of the phosphopeptide but not by a nonphosphopeptide 
(Figure S2C). To further test the specificity of the antibody, we 
cotransfected HeLa cells with green fluorescent protein (GFP)-
tagged variants of wild-type NCoR, NCoRS2143/2144A, NCoRS2436A, 
and/or Myc-tagged CK2α. Cell lysates were immunoprecipitated 
with GFP antibody and subjected to Western blot analysis using the 
NCoR Ser(P)-2436 antibody. The phosphospecific antibody de-
tected Ser-2463 in NCoRWT and the NCoRS2143/2144A double mutant, 
but not in the NCoRS2436A mutant. As a control, TBB treatment com-
pletely blocked recognition of NCoRWT by the NCoR Ser(P)-2436 
antibody, confirming the specificity of the phosphospecific antibody 
(Figure 1F). Notably, TBB treatment greatly reduced both NCoR 
repression (Tiefenbach et al., 2006). IKKα kinase has been shown to 
be recruited to chromatin in response to various stimuli; once local-
ized, it phosphorylates SMRT at Ser-2410. SMRT phosphorylation 
leads to nuclear export and proteasomal degradation, reducing re-
pression (Hoberg et al., 2004). In addition to IKKα, casein kinase 2 
(CK2) phosphorylates SMRT on Ser-1492, which stabilizes the asso-
ciation between SMRT and thyroid hormone receptors, thus enhanc-
ing repression (Zhou et al., 2001). Importantly, although the C-termi-
nal domain of NCoR also possesses the same CK2 phosphorylation 
site as SMRT, the effect of CK2-mediated NCoR phosphorylation on 
its function has not been explored.
CK2 is a multifunctional protein kinase with over 300 substrates, 
many of which are critically involved in cell cycle control, cellular dif-
ferentiation, proliferation, and metabolic pathways (Ruzzene and 
Pinna, 2010). Additionally, CK2 dysregulation in tumor cells may in-
fluence apoptotic activity and enhance cell survival (Guo et al., 
2001). Furthermore, CK2 expression levels and activities are known 
to be increased three- to fivefold in many tumors and tumor cell 
lines (Trembley et al., 2009). In transgenic mice, CK2 overexpression 
cooperates with c-myc or loss (or mutation) of p53 at the lpr locus to 
promote tumorigenesis (Landesman-Bollag et al., 2001). CK2 plays 
a positive role in Wnt/β-catenin signaling via β-catenin phosphoryla-
tion at Thr-393, leading to proteasomal resistance and increased 
cotranscriptional activity (Song et al., 2003). Importantly, CK2 par-
ticipates in the control of Snail1, a major factor for the epithelial–
mesenchymal transition (EMT), by stabilizing and positively regulat-
ing the repressive function of Snail1 and its interaction with the 
corepressor mSin3A (MacPherson et al., 2010). CK2 also phospho-
rylates osteopontin, a protein that correlates with tumor invasion, 
progression, or metastasis in multiple cancers, including cancers of 
the breast, stomach, lung, prostate, liver, and colon (Christensen 
et al., 2005; Trembley et al., 2009; Giusiano et al., 2010). Addition-
ally, emodin, a selective inhibitor of CK2 activity, significantly inhibits 
invasion of human tongue cancer SCC-4 cells by MMP-9 down-reg-
ulation (Chen et al., 2010). Although aberrant expression of CK2 is 
known to be involved in many cancers, the mechanism by which 
CK2 promotes tumorigenesis remains obscure.
In this study, we found that CK2α directly bound and phosphory-
lated the C-terminal domain of NCoR. We show that CK2α-mediated 
phosphorylation stabilized NCoR against ubiquitin-dependent pro-
teasomal degradation. We also show that CK2α-dependent NCoR 
phosphorylation is required for transcriptional repression of 
interferon-γ–inducible protein 10 (IP-10) and invasion of esophageal 
cancer cells. This study unravels the unique role of the CK2α-NCoR 
oncogenic cascade in human esophageal cancer cells.
RESULTS
CK2α specifically interacts with the nuclear hormone 
receptor interacting domain (NRID) of NCoR and 
phosphorylates the C-terminal NRID domain
To elucidate the functional role of the NCoR protein in cellular sig-
naling, we first attempted to identify NCoR-interacting proteins us-
ing yeast two-hybrid screening. Human HeLa and testis cyclic DNA 
(cDNA) libraries were screened using multiple NCoR domains. 
Based on sequence analysis, CK2α was selected as a putative 
NCoR-interacting protein (unpublished data). To confirm the yeast 
two-hybrid assay results, we performed in vitro and in vivo pulldown 
assays. Immunoprecipitation analysis revealed that Myc-tagged 
CK2α specifically interacted with endogenous NCoR protein. Con-
sistently, reciprocal immunoprecipitation analysis verified the en-
dogenous interaction between NCoR and CK2α (Figure 1A). Map-
ping analysis using GST pulldown and immunoprecipitation assays 
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those of control (Figure S2E). Importantly, the phosphopeptide, but 
not the nonphosphopeptide, completely blocked phosphorylation 
of NCoR. More importantly, TBB treatment completely abrogated 
endogenous NCoR phosphorylation by PLA analysis (Figure 1H). 
These data clearly indicated CK2α-dependent NCoR phosphoryla-
tion in vivo. Finally, to confirm that the modification by CK2 occurs at 
Ser-2436, the nonphosphopeptide corresponding region between 
residues 2431 and 2440 of NCoR was incubated with immunopre-
cipitated CK2 and/or TBB and subjected to matrix-assisted laser 
desorption ionization time-of-flight analysis. A peptide with molecu-
lar mass corresponding to the Ser-2436–phosphorylated peptide 
and NCoR phosphorylation levels, implying a functional role of 
CK2α-mediated phosphorylation in NCoR stability.
To verify the in vivo NCoR phosphorylation by CK2α, we per-
formed a proximity ligation assay (PLA) using the Duolink in situ PLA 
kit (Soderberg et al., 2006). NCoR-15/16WT protein was efficiently 
phosphorylated in HeLa cells (Figure 1G), whereas TBB treatment in 
the same cells resulted in loss of phosphorylation events similar to 
that seen with the control plasmid (Figure S2D). Consistently, FLAG-
tagged NCoR-15/16S2143/2144A showed similar patterns of phosphory-
lation compared with NCoR-15/16WT; however, mutant FLAG-tagged 
NCoR-15/16S2436A displayed no phosphorylation events similar to 
FIGURE 1: CK2α phosphorylates Ser-2436 of NCoR. (A) Reciprocal immunoprecipitation analysis was performed using 
HeLa cell lysates with a CK2α or NCoR antibody, and immunoblotting was performed using their respective antibodies 
(right). HeLa cells were transfected with Myc-CK2α, and cell lysates were immunoprecipitated and immunoblotted with 
their respective antibodies (left). (B) A schematic of the deletion mutants of NCoR for in vitro translation (left). Bound 
proteins were eluted and analyzed by autoradiography (right, top). HeLa cells were transfected with FLAG-tagged 
NCoR-15/16 (1985–2440) and HA-tagged CK2α plasmids. Whole-cell lysates were immunoprecipitated and 
immunoblotted with the indicated antibodies (right, bottom). (C and D) In vitro kinase assays were performed with 
CK2α and the indicated GST-fused NCoR-15/16 proteins. Bound proteins were eluted and analyzed by autoradiography 
(C) and scintillation counter (D). (E) In vitro kinase assays were performed with recombinant CK2α enzyme and the 
indicated GST-fused NCoR-15/16 proteins. Western blotting was performed with phospho-NCoR antibody. CBB, 
Coomassie blue staining. (F) Full-length GFP-NCoR plasmids were transfected into HeLa cells with or without Myc-CK2α 
and treated with TBB (50 μM) for 6 h. Cell lysates were analyzed by Western blotting with indicated antibodies. (G) HeLa 
cells were seeded on coverslips and transfected with the indicated expression plasmids in the presence or absence of 
TBB (50 μM). The permeabilized HeLa cells were incubated with indicated antibodies and/or 1 μg/ml of non-
phosphopeptide (NPP) or phosphopeptide (PP) for 12 h, which was followed by PLA probes (PLUS and MINUS) 
treatment. The positive signal was analyzed using confocal microscopy. (H) In situ PLA analysis was performed under the 
same conditions as above without transfection of expression plasmids. The level of NCoR phosphorylation was assessed 
with αNCoR antibody and α-phospho-NCoR antibody.
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phorylation and stability of endogenous NCoR. As expected, TBB 
treatment dramatically reduced NCoR phosphorylation and stability, 
whereas MG132 treatment reversed NCoR stability (Figure 2B). Ad-
ditionally, a time-course experiment with cycloheximide treatment 
again verified that CK2-dependent phosphorylation maintains 
NCoR stability (Figures 2C and S4A). Interestingly, the subcellular 
localization of dephosphorylated NCoR was similar to that seen in 
the control, indicating that CK2-dependent phosphorylation had no 
effect on the cellular distribution of NCoR (Figure 2D).
We next sought to examine the knockdown effect of CK2 on 
NCoR stability. We designed small interfering RNAs (siRNAs) against 
CK2 and NCoR. After establishing the specific knockdown efficiency 
of each siRNA by Western blot analysis (Figure 2E), we performed 
immunostaining analysis in HeLa cells after treatment with siNCoR, 
siCK2, TBB, or another specific inhibitor against CK2, Emodin. Both 
was observed after addition of CK2, whereas TBB treatment failed to 
show the peak corresponding to the phosphorylated peptide (Figure 
S3). Together these data establish that Ser-2436 is a major NCoR 
phosphorylation site in vivo and can be activated by CK2.
CK2 stabilizes NCoR via inhibition of the ubiquitin-
dependent proteasomal degradation pathway
To elucidate the effect of CK2-mediated phosphorylation on the 
function of NCoR, we first examined whether CK2-dependent phos-
phorylation affected the stability of the NCoR protein. TBB treat-
ment dose-dependently decreased both expression and phospho-
rylation of full-length NCoRWT; however, TBB had a negligible effect 
on NCoRS2436A (Figure 2A). Interestingly, MG132 treatment restored 
the TBB-induced decrease in the level of NCoRWT relative to 
NCoRS2436A. To confirm this result, we examined the level of phos-
FIGURE 2: CK2α-dependent NCoR phosphorylation increases NCoR stability via inhibition of the ubiquitin-dependent 
proteasomal pathway. (A) HeLa cells were transfected with full-length GFP-NCoR plasmids and treated with an increase 
amount of TBB (10, 50, 100 μM) and/or MG132 (10 μM) for 6 h. Cell lysates were analyzed by Western blotting. (B) HeLa 
cells were treated with an increase amount of TBB (10, 50 μM) and/or MG132, and cell lysates were analyzed by 
Western blotting with indicated antibodies. (C) HeLa cells were transfected with either FLAG-NCoR-15/16WT or 
FLAG-NCoR-15/16S2436A plasmid. After 2 d, cells were treated with cycloheximide (10 μg/ml), TBB (50 μM), and/or 
MG132 for various time periods, and cell lysates were analyzed by Western blotting. (D) HeLa cells were treated with 
TBB (50 μM) and/or MG132, and endogenous NCoR and phospho-NCoR levels were analyzed by confocal microscopy. 
(E and F) HeLa cells were treated with TBB (50 μM) or siRNAs against NCoR or CK2α, and then protein and mRNA 
levels were analyzed by Western blotting (E) and RT-PCR (F), respectively. (G) HeLa cells were treated with emodin 
(50 μM), TBB, LiCl2, and indicated siRNAs, and endogenous NCoR levels were then analyzed by confocal microscopy. 
(H) HeLa cells were treated with indicated inhibitors or siRNAs, and cell lysates were analyzed by Western blotting. 
(I) FLAG-NCoR-15/16 plasmids and HA-ubiquitin (Ub) were transfected into HeLa cells with TBB and/or MG132, and cell 
lysates were analyzed by Western blotting.
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As MG132 treatment blocked TBB-in-
duced degradation of NCoR, we investi-
gated whether inhibition of NCoR phospho-
rylation by TBB induced the ubiquitination 
of NCoR. TBB treatment increased the ubiq-
uitination of the NCoR-15/16WT domain and 
MG132 treatment further enhanced the ef-
fect by TBB (Figure 2I). Furthermore, ubiq-
uitination of NCoR-15/16S2436A was greatly 
increased by MG132 compared with both 
NCoR-15/16WT and NCoR-15/16S2143/2144A. 
Collectively these data indicate that CK2-
dependent phosphorylation is critical for 
NCoR stability via the ubiquitin-dependent 
proteasomal degradation pathway.
NCoR promotes the invasion of cancer 
cells in a CK2-dependent manner
Two esophageal cancer cell lines, TE2 and 
HCE4, display opposing levels of CK2 activi-
ties with a similar level of CK2 itself (Shin 
et al., 2005). We therefore examined the bi-
ological importance of CK2-mediated NCoR 
phosphorylation using these cells as a model 
system. To confirm the previous report, we 
first assessed the relative activity of CK2 in 
both lines. In vitro kinase assays revealed 
that CK2 activities in both HCE4 and TE2-
CK2 cells that stably express CK2 are five-
fold higher than in TE2 cells (Figures 3A and 
S6); however, TBB treatment of HCE4 cells 
decreased CK2 activity. Importantly, the pat-
terns of NCoR expression and phosphoryla-
tion were well associated with those of CK2 
activity (Figure 3B). Consistently, TBB treat-
ment greatly reduced both phosphorylation 
and stability of NCoR in HCE4 cells, whereas 
MG132 treatment restored the reduced 
NCoR level induced by TBB treatment (Figure 3C). To confirm these 
results, we performed in situ PLA analysis to compare endogenous 
levels of NCoR and phospho-NCoR in both cancer cell lines. Consis-
tent with the Western blot analysis, positive signals from HCE4 cells 
were higher than those from TE2 cells, and TBB treatment decreased 
the phospho-NCoR level in HCE4 cells, confirming that NCoR phos-
phorylation levels are well associated with patterns of CK2 activities 
in both cancer cell lines (Figure 3D).
Because multiple clinical observations have implicated CK2 in 
tumorigenesis of cancer cells (Trembley et al., 2009), we investi-
gated whether NCoR is required for CK2-mediated invasion of 
esophageal cancer cells. The invasiveness of HCE4 and CK2-over-
expressing TE2 cells were sevenfold higher than that of TE2 cells 
(Figure 4A). The patterns of invasion activity in both cancer cell lines 
are closely correlated with CK2 activity, as either TBB treatment or 
knockdown of CK2 efficiently reversed the invasiveness of both cell 
types (Figure 4B). Interestingly, combinatorial treatment with siRNAs 
against NCoR and TBB synergistically suppressed the invasiveness 
of HCE4 cancer cells as compared with individual treatment (Figures 
4C, S7, and S8A). More interestingly, overexpression of mutant 
NCoRS2436A protein failed to enhance the invasiveness of HCE4 cells 
compared with wild-type NCoR, suggesting that CK2-mediated 
phosphorylation of NCoR is crucial for NCoR-mediated invasion of 
cancer cells. These data collectively demonstrate a crucial role of 
knockdown of CK2 and inhibition of CK2 activity dramatically re-
duced the endogenous NCoR level, likely silencing NCoR (Figures 
2G and S4B). Consistently, MG132 treatment dramatically restored 
the level of endogenous NCoR (Figure 2D) without affecting the 
level of NCoR phosphorylation. Notably, CK2 knockdown led to re-
duced NCoR protein levels, but not reduced NCoR mRNA levels, 
further supporting our notion that CK2 plays an important role in 
NCoR stability (Figure 2E). Because SMRT is known to be phospho-
rylated by CK2, we examined whether CK2-dependent phosphory-
lation is also required for SMRT stability. Either depletion of CK2 or 
TBB treatment had no effect on SMRT levels, suggesting the differ-
ential effect of CK2-dependent phosphorylation on both proteins 
(Figure 2, F and H). Notably, NCoR stability was specifically abol-
ished by only TBB and not by other kinase-specific inhibitors (Figure 
2H). Because a previous study showed NCoR is degraded following 
overexpression of Siah1 (Perissi et al., 2004), we investigated 
whether CK2-mediated phosphorylation of NCoR suppresses the 
Siah1-mediated degradation of NCoR. Consistent with previous 
findings, overexpression of Siah1 reduced the stability of endoge-
nous NCoR, whereas overexpressed CK2 efficiently blocked the 
Siah1-mediated degradation of NCoR. As expected, TBB treatment 
again reduced the stability of NCoR, indicating that phosphoryla-
tion of NCoR by CK2 antagonizes the Siah1-mediated NCoR degra-
dation (Figure S5).
FIGURE 3: The levels of NCoR phosphorylation at Ser-2436 are well associated with patterns of 
CK2α activities. (A) In vitro kinase assays were performed by incubation of GST-NCoR-15/16 
protein and immunoprecipitated CK2α enzyme from TE2, TE2-CK2α and HCE4 cells, and CK2α 
phosphorylation levels were analyzed by autoradiography and scintillation counter. (B) Whole-
cell lysates from TE2 and HCE4 cells were analyzed by Western blotting. (C) HCE4 cells were 
treated with TBB (10, 50 μM) and/or MG132 for 6 h, and cell lysates were analyzed by Western 
blotting. (D) TE2, TE2-CK2α, and HCE4 cells were seeded on coverslips and treated with or 
without TBB (50 μM). Permeabilized cells were incubated with a phosphospecific NCoR 
antibody, an NCoR antibody, and PLA probes. Duolink in situ PLA analysis was performed as 
described in Materials and Methods.
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that 64 and 9 genes were derepressed by siCK2 and siNCoR treat-
ment, respectively (Figures 5A and S8B). Among genes derepressed 
by depletion of either CK2 or NCoR, those coderepressed by more 
than twofold were selected. Four genes were identified: topomyo-
sin 4 (TPM4), opioid growth factor receptor (OGFR), interferon-in-
duced protein with tetratricopeptide repeats 1 (IFIT1), and IP-10. 
Both reverse transcriptase (RT)-PCR and real-time PCR analysis vali-
dated the cDNA microarray analysis results, confirming the dere-
pression of the four genes by knockdown of either CK2 or NCoR 
and the differential expression of the four genes in both TE2 and 
HCE4 cells (Figures 5B and S8C). These results revealed that the 
four genes are novel CK2-NCoR cascade–regulated genes.
Among them, IP-10 (CXCL10) promotes cell-mediated immunity 
and inhibits proliferation and metastasis in many tumors (Tominaga 
et al., 2007; Mei et al., 2008; Enderlin et al., 2009). Additionally, IP-
10 is a putative NCoR target gene with an activator protein 1 (AP1) 
site for the recruitment of c-Jun (Ghisletti et al., 2009). We therefore 
chose this gene as a putative NCoR target gene and examined how 
NCoR modulates the invasion of cancer cells in a CK2-dependent 
manner. To confirm the selective involvement of NCoR and CK2 in 
the transcriptional regulation of IP-10, we assessed the level of an-
other metastasis-related gene, CXCL12. Both knockdown of CK2 
and NCoR commonly derepressed IP-10 transcription; however, the 
transcriptional level of CXCL12 was not altered, suggesting the 
NCoR in CK2-mediated invasion of cancer cells. Importantly, CK2 is 
known to phosphorylate E-cadherin and the positive regulator 
Snail1, a major factor for EMT. Thus we examined whether the CK2-
NCoR network is also required for down-regulation of E-cadherin. 
E-cadherin levels were greatly decreased in HCE4 cells and dere-
pressed with TBB or siCK2 treatment (Figure 4D). This reversed pat-
tern of E-cadherin expression likely depends on the level of CK2, 
but not of NCoR, because silencing of NCoR had a negligible effect 
on the levels of E-cadherin. Furthermore, the depletion of both CK2 
and NCoR had no effect on the elevated level of another tumor 
metastasis marker protein, vimentin. These data suggest that NCoR 
plays a role in CK2-dependent invasion of tumor cells via an alterna-
tive pathway.
CK2-NCoR cascade represses the transcription of the 
anti-tumorigenic gene IP-10 to promote the invasion 
of esophageal cancer cell
Given the significant role of CK2-induced NCoR phosphorylation in 
the invasion of cancer cells, we sought to unravel how NCoR modu-
lates the tumorigenicity of cancer cells in a CK2-dependent manner. 
Because NCoR is a well-known transcriptional corepressor for di-
verse transcription factors via suppression of specific target genes 
(Perissi et al., 2010), we screened tumorigenesis-related genes regu-
lated by the CK2-NCoR cascade. cDNA microarray analysis revealed 
FIGURE 4: NCoR promotes the invasion of esophageal cancer cells in a CK2α-dependent manner. (A) Invasion was 
analyzed by counting cells that migrated through the extracellular matrix layer of BioCoat Matrigel invasion chambers. 
Data are expressed as the means ± SD of at least three independent experiments. (B) Both TE2-CK2α and HCE4 cells 
were transfected with siRNAs against NCoR and/or TBB (50 μM) before application to the upper chamber. Data are 
expressed as the means ± SD of at least three independent experiments. (C) HCE4 cells were treated with individual 
siNCoRs, GFP-NCoR plasmids, and/or TBB, and invasion was analyzed by counting cells that migrated through the 
extracellular matrix layer of BioCoat Matrigel invasion chambers. *, p < 0.05 vs. siCon; **, p < 0.01 vs. siCon + TBB. 
(D) Either TE2 or HCE4 cell was treated with indicated siRNAs or TBB, and cell lysates were analyzed by Western blotting.
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tion was selectively derepressed by depletion of Snail1, but not by 
depletion of NCoR. Conversely, the derepression of IP-10 was ob-
served only upon NCoR knockdown (Figures 5F and S9). Strikingly, 
CK2 failed to repress transcription of IP-10 and E-cadherin in the 
depletion of NCoR and Snail1, respectively, indicating that the CK2-
mediated signaling network coordinately regulates the transcription 
of downstream target genes to promote oncogenesis by adapting 
to different sets of corepressor complexes (Figures 5G and S10).
Because NCoR corepressor complexes are known to mainly re-
press transcription via deacetylation of histone tails, we examined 
whether both NCoR and HDAC3 are recruited to the AP1-binding 
site of IP-10 via c-Jun to subsequently induce hypoacetylation of 
selective regulation of IP-10 transcription by the CK2 and NCoR sig-
naling network (Figure 5C). Notably, TBB inhibitors commonly dere-
pressed IP-10 transcription (Figure 5D). Importantly, the knockdown 
of SMRT had no effect on the derepression of IP-10, emphasizing 
the unique role of NCoR in the transcriptional repression of IP-10 
(Figure 5C). More importantly, knockdown of HDAC3, but not other 
class I HDACs, specifically relieved the transcriptional repression of 
IP-10 in a manner similar to siNCoR treatment, demonstrating the 
crucial role of the NCoR-HDAC3 axis in the transcriptional repres-
sion of IP-10 (Figure 5E). CK2 also promotes Snail1-mediated tran-
scriptional repression of E-cadherin, which is critical for suppression 
of EMT (MacPherson et al., 2010). Intriguingly, E-cadherin transcrip-
FIGURE 5: NCoR selectively represses transcription of the anti-tumorigenic gene IP-10/CXCL10 in a CK2α-dependent 
manner. (A) HCE4 cells were transfected with siRNA against NCoR and CK2α, and the change in mRNA expression was 
analyzed by cDNA microarray analysis using the Illumina HumanRef-8 version 3 Expression BeadChip. Data outputs and 
the average intensity for each array were normalized against housekeeping genes located on each array. Differentially 
expressed genes were identified by comparison of the siCK2 sample set with the small-interfering control sample set, 
and the siNCoR-2 sample set with the small-interfering control sample set using p < 0.05 as the significance cutoff. Only 
fold changes greater than 2.0 were considered. (B) HCE4 cells were treated with siRNAs, and the levels of indicated 
genes were analyzed by real-time PCR (left). The relative levels of indicated genes between TE2 and HCE4 cells were 
analyzed by real-time PCR (right). All samples were normalized to human GAPDH. (C) HCE4 cells were treated with TBB 
(50 μM, 6 H) or indicated siRNAs, and the level of each gene was analyzed by real-time PCR. (D) HCE4 cells were 
treated with an increasing amount of indicated inhibitors, and then mRNAs were analyzed by real-time PCR. (E) HCE4 
cells were treated with siRNAs against each HDAC, and the level of each gene was analyzed by real-time PCR. (F) HCE4 
cells were treated with TBB (50 μM, 6 H) or indicated siRNAs, and the level of each gene was analyzed by real-time PCR. 
(G) TE2 cells were transfected with CK2α plasmid. After 24 h, cells were treated with indicated siRNAs or TBB (50 μm, 
6 H), and the levels of the indicated genes were analyzed by real-time PCR. *, p < 0.01 vs. CK2α alone; **, p < 0.05 vs. 
CK2α alone; #, p < 0.05 vs. CK2α +.siCon; # #, p < 0.05 vs. CK2α + siCon.
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nonepigenetic role of CK2 in NCoR-mediated transcriptional re-
pression of IP-10. Coincidently, TBB treatment resulted in an in-
crease in histone acetylation and recruitment of the histone acetyl-
transferase p300, which corresponds with transcriptional activation 
of IP-10 (Figure 6B). More importantly, ChIP and reChIP experi-
ments demonstrated that the phosphorylated form of NCoR 
was mainly bound to the AP1 site of the IP-10 gene (Figure 6C). 
Because recruitment of Fos to the AP1 site was substantially in-
creased in response to TBB treatment, we concluded that CK2 
controls c-Jun-NCoR corepressor complex–mediated transcrip-
tional repression of IP-10 by preventing recruitment of c-Jun-Fos 
coactivator complexes to IP-10 (Figure 6B). Collectively these re-
sults show that NCoR complexes selectively repress IP-10 tran-
scription at the epigenetic status via deacetylation of histone tails 
in a CK2-dependent manner.
Finally, the functional consequences of CK2-NCoR cascade–me-
diated transcriptional repression of IP-10 with respect to invasive-
ness of tumor cells were examined using a Matrigel invasion assay. 
CK2 overexpression consistently increased the invasion of TE2 cells; 
however, IP-10 restoration suppressed the CK2-induced invasion of 
chromatin, ultimately leading to transcriptional repression. We first 
identified the AP1 site in human IP-10, because c-Jun is known to 
recruit NCoR to AP1 sites on NCoR target genes. A putative AP1 
consensus sequence was identified at position −2050 (relative to 
the transcription start site) by sequence mining of IP-10 (Figure 
6A). Specific PCR primers were designed to amplify sequences 
(100–150 bp) surrounding the putative AP1-binding site (P1) and 
coding region (P2) of the IP-10 gene (Figure 6A). Chromatin im-
munoprecipitation (ChIP) experiments showed the presence of c-
Jun on the AP1-binding site of IP-10. Under the same experimental 
conditions, both NCoR and HDAC3 were also recruited to the AP1 
site of IP-10 in HCE4 cells, whereas reduced binding of HDAC3 
was observed in siNCoR- and siCK2-treated HCE4 cells, presum-
ably due to the decreased NCoR levels at the AP1 site (Figure 6A, 
P1). As controls, neither NCoR nor HDAC3 associated with the 
coding region of the IP-10 gene (Figure S11A, P2). Consistent with 
previous studies, knockdown of c-Jun greatly abolished recruit-
ment of the NCoR-HDAC3 complex to the AP1 site of IP-10 (Figure 
S11B, P1). Importantly, the recruitment of CK2 to the AP1 site of 
IP-10 was not observed regardless of TBB treatment, indicating the 
FIGURE 6: NCoR complexes repress IP-10 transcription at the epigenetic status via deacetylation of histone tails in a 
CK2α-dependent manner. (A and B) HCE4 cells were treated with TBB (50 μM, 6 H) or indicated siRNAs, and ChIP 
assays were performed with the indicated antibodies. The precipitated samples were analyzed by real-time PCR, and 
results are given as the percentage of input as means ± SD of three independent experiments. *, p < 0.005 vs. SiCon; #, 
P < 0.01 vs. SiCon; **, p < 0.05 vs. SiCon. (C) ChIP and reChIP assays were performed with the indicated antibodies. 
Error bars, SD (n = 3). *, p < 0.05 vs. IgG; **, p < 0.01 vs. IgG. (D) TE2 cells were transfected with indicated siRNAs and/
or plasmids, and treated with TBB (50 μM, 6 H). The invading cells were counted in BioCoat Matrigel invasion chambers. 
(E) Model of our findings. In tumor cells with high CK2α activity, active CK2α phosphorylates NCoR and HDAC3 to 
repress IP-10 transcription, enhancing tumorigenesis. Additionally, CK2α phosphorylates Snail1 to repress E-cadherin 
transcription via an NCoR-independent pathway. Thus selective CK2α inhibition may be promising for anticancer 
therapy.
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c-Jun N-terminal phosphorylation. Thus the exchange between 
corepressors and coactivators in c-Jun–mediated transcriptional 
regulation seems to be coordinately regulated by JNK-mediated 
phosphorylation. Interestingly, the component of NCoR corepres-
sor complex, GPS2, was shown to inhibit the JNK-mediated c-Jun 
phosphorylation in an NCoR-dependent manner (Zhang et al., 
2002). Thus a plausible model would show GPS2 inhibiting the 
JNK-mediated phosphorylation of c-Jun to induce the binding of 
NCoR-HDAC3 corepressor complex to c-Jun, which would finally 
lead to the transcriptional repression of the IP-10 gene. Future 
studies to investigate the role of GPS2 on the c-Jun-NCoR com-
plex–mediated transcriptional repression of target genes will be 
interesting.
Analysis of the phosphorylation site in NCoR revealed that the 
CK2α phosphorylation motif of NCoR is identical to that of SMRT. 
Thus we initially expected an effect of CK2-dependent phosphory-
lation on the function of NCoR similar to that seen with SMRT. Inter-
estingly, we found that silencing or inhibiting CK2α resulted in a re-
duced NCoR level, and MG132 treatment efficiently blocked the 
ubiquitin-dependent proteasomal degradation of NCoR. The effect 
of CK2α-dependent phosphorylation on protein stability was found 
to be unique to NCoR, because both CK2α knockdown and TBB 
treatment had no effect on SMRT levels. Notably, other kinase in-
hibitors failed to affect NCoR stability, indicating the unique role of 
CK2α in the regulation of NCoR stability. It is also noteworthy that 
the effect of TBB on NCoR stability seems to be greater than CK2 
knockdown by siRNA. Because TBB is not absolutely unique to 
CK2α, we could not exclude the possibility of another regulatory 
mechanism for NCoR stability. Furthermore, the result from ChIP 
assays displayed the selective recruitment of NCoR, but not SMRT, 
to the AP1 site of IP-10. Thus, for the first time, we provide evidence 
for the differential effect of CK2-dependent phosphorylation on the 
function of SMRT and NCoR protein. In addition to regulating SMRT 
and NCoR function, CK2-mediated HDAC3 phosphorylation en-
hances histone deacetylase activity and nuclear translocation, lead-
ing to enhanced repressive function (Zhang et al., 2005). Our results 
show that TBB treatment also blocks HDAC3 phosphorylation, as 
well as HDAC activity (unpublished data), leading to down-regula-
tion of IP-10. Furthermore, silencing of HDAC3 also selectively dere-
presses IP-10 transcription in a manner similar to siNCoR or siCK2, 
suggesting the functional engagement of NCoR-HDAC3 corepres-
sor complex in transcriptional repression of IP-10. These data col-
lectively suggest that CK2 phosphorylates both NCoR and HDAC3, 
which enhances NCoR stability and HDAC3 activity and leads to in-
creased potency and integrity of the NCoR-HDAC3 corepressor 
complex for IP-10 transcriptional repression.
IP-10 has recently been shown to inhibit growth, angiogenesis, 
and metastasis in experimental tumors (Keyser et al., 2004; Tomi-
naga et al., 2007; Mei et al., 2008). In addition, several clinical stud-
ies have demonstrated that the down-regulated IP-10 correlated 
with poor patient prognosis in human cancer (Sato et al., 2007; Ji-
ang et al., 2010). Thus the suppression of IP-10 expression might 
result in drastic tumor growth and metastasis that accelerates tumor 
advancement. Intriguingly, as seen in our cDNA microarray data, 
IP-10 has been identified as a putative NCoR target gene containing 
an AP1 site for the recruitment of c-Jun (Ghisletti et al., 2009). Thus 
we hypothesized that CK2 phosphorylates NCoR to promote the 
tumorigenic growth of cancer cells with IP-10 down-regulation. Di-
verse analysis of the invasion of HCE4 cells showed that NCoR mod-
ulates the invasiveness of cancer cells via transcriptional repression 
of IP-10 in a CK2-dependent manner. Consistently, overexpression 
of IP-10 had an opposite effect on the invasion of HCE4 cells. These 
TE2 cells in a manner similar to NCoR and CK2 knockdown. The in-
creased invasiveness of TE4 cells by CK2 seems to be NCoR-depen-
dent, because the depletion of NCoR diminished the CK2-enhanced 
invasion of TE2 cells (Figure 6D). Further, the chorioallantoic mem-
brane (CAM) assay again verified that the CK2-mediated invasion of 
HCE4 cells is dependent on NCoR by showing that siNCoR-treated 
HCE4 cells displayed complete loss of the tissue-invasive pheno-
type (Figure S12). These data collectively suggest that the CK2-
NCoR cascade promotes invasiveness of tumor cells by transcrip-
tional repression of IP-10.
DISCUSSION
Many studies have shown that elevated levels of CK2 are associ-
ated with tumorigenesis (Trembley et al., 2009). High CK2 activity 
levels accelerated the formation and development of squamous 
cell cancer of the head and neck, lung squamous cell carcinoma, 
and metastatic breast and prostate cancer (Gapany et al., 1995; 
Faust et al., 2000; Babiker et al., 2006; Giusiano et al., 2010). 
Moreover, CK2-specific inhibitors significantly inhibited membrane 
invasion, adhesion, and migration of ovarian carcinoma cells. CK2 
phosphorylates a broad spectrum of nuclear as well as cytoplasmic 
proteins in multiple aspects of gene expression (Ruzzene and 
Pinna, 2010). Importantly, a recent study has functionally impli-
cated CK2 in E-cadherin down-regulation. Snail1 is known to be a 
transcriptional repressor of E-cadherin transcription and is also 
phosphorylated by CK2, leading to enhanced Snail1 stability and 
subsequent increase in E-cadherin transcriptional repression. For 
E-cadherin transcriptional repression, Snail1 has been shown to 
selectively interact with another corepressor complex, mSin3-
HDAC1, but not with NCoR-SMRT (Peinado et al., 2004). Our re-
sults demonstrate that CK2α phosphorylates NCoR to selectively 
repress transcription of the novel NCoR target gene IP-10 and to 
enhance tumorigenesis without correlating with EMT and migra-
tion, because Snail1 knockdown had no effect on IP-10 expression. 
Moreover, NCoR knockdown had no effect on E-cadherin tran-
scription. The exclusive roles of HDAC-containing corepressor 
complexes in transcriptional repression of a subset of target genes 
have been emphasized by several studies. For instance, previous 
studies regarding transcriptional repression of the thyroid hor-
mone receptor (TR) target gene deiodinase 1 (D1) have shown se-
lective recruitment of unliganded TR-NCoR-HDAC3 complexes to 
the promoter region of D1 (Yoon et al., 2005). Furthermore, exclu-
sive recruitment of sin3A-HDAC1-HDAC2 complexes to the en-
dogenous E-cadherin promoter was shown, but not with other 
class I HDAC corepressor complexes, including HDAC3, indicating 
the unique role of corepressor complexes in the transcription re-
pression of respective target genes (Peinado et al., 2004).
Proto-oncoprotein c-Jun, which interacts with c-Fos protein to 
form a heterodimer, plays an important role in the transcriptional 
regulation, signal transduction, and tumorigenesis (Eferl and 
Wagner, 2003; Sancho et al., 2009). c-Jun was recently shown to 
recruit NCoR to AP1 sites on NCoR-specific promoters to mediate 
anti-inflammatory signals (Ghisletti et al., 2009). Our ChIP analysis 
also showed that c-Jun recruits NCoR-HDAC3 corepressor com-
plexes to the AP1 site of IP-10 promoter along with the dissocia-
tion of c-Fos, leading to the histone hypoacetylation. Notably, TBB 
treatment induced the reassociation of c-Fos with c-Jun on the 
AP1 site of the IP-10 gene along with the detachment of NCoR 
from c-Jun. These data are reminiscent of the c-Jun-Mbd3-NuRD 
repressor complex in the repression of intestinal stem cell marker 
lgr5 (Aguilera et al., 2011). In that study, the assembly of c-Jun-
Mbd3-NuRD repressor complex was relieved by JNK-mediated 
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results confirmed the regulatory role of the CK2-NCoR cascade in 
the anti-tumorigenic effect of IP-10. Because IP-10 is known to be 
involved in antitumor immune responses via induction of cytotoxic 
T-lymphocyte migration to the tumor site (Huang et al., 2002), we 
cannot exclude the possibility that CK2-NCoR cascade–mediated 
IP-10 down-regulation results in immune evasion of cancer cells, 
possibly leading to oncogenesis. Importantly, failure of the dere-
pression of IP-10 by depletion of Snail1 again confirmed our notion 
that the CK2 signaling cascade likely promotes the invasion of tu-
mor cells by suppressing a subset of genes with selective recruit-
ment of corepressor complexes.
In summary, this study shows that CK2 promotes tumorigenesis 
via NCoR-dependent repression of the IP-10 gene, which is inde-
pendent of the Snail1-mediated EMT pathway. This work provides in 
vivo evidences that the CK2-NCoR signaling network selectively 
suppresses the transcription of IP-10 to promote invasion of human 
cancer cells. Thus this study highlights the importance of the novel 
CK2-NCoR signaling network in tumorigenesis (Figure 6D).
MATERIALS AND METHODS
Cell culture, plasmids, and antibodies
The human cervical epithelial adenocarcinoma cell line HeLa as well 
as two human esophageal cancer cell lines, TE2 and HCE4, were 
cultured in DMEM (Life Technologies, Gaithersburg, MD) supple-
mented with 10% (vol/vol) fetal bovine serum (FBS; Life Technolo-
gies), 100 U/ml penicillin (Life Technologies), and 0.1 mg/ml strepto-
mycin (Life Technologies) at 37°C under 5% CO2. MG132 was 
purchased from Calbiochem (Bad Soden, Germany), and a 10 mM 
stock was prepared in dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. 
Louis, MO). The TE2-CK2 stable cell line that expresses CK2α was 
kindly provided by Kunhong Kim (Yonsei University, Seoul, Korea) 
and cultured in DMEM. The CK2 inhibitor TBB was prepared as a 50 
mM stock solution in DMSO (Sigma-Aldrich). Control cultures re-
ceived the same amounts of DMSO as experimental cultures, and 
final DMSO concentrations did not exceed 0.1%. Transient transfec-
tion was performed using Polyexpress (Excellgene, Gaithersburg, 
MD). Additionally, several kinase inhibitors, including LiCl2 (GSK3β 
inhibitor; Amresco, Cleveland, OH), SP600125 (JNK1 inhibitor; As-
say Designs, Ann Arbor, MI), SB-203580 (MEK-inhibitor; Assay De-
signs), wortmannin (PI3K inhibitor; Assay Designs), Akt inhibitor (Cal-
biochem), ERK inhibitor (Calbiochem), and H89 (PKA inhibitor; Assay 
Designs) were used to investigate the stabilization of NCoR1. The 
following antibodies were used: anti-CK2 (Upstate, Charlottesville, 
VA), anti-hemagglutinin (anti-HA; Sigma-Aldrich, and Covance, New 
York, NY), anti-FLAG (Sigma-Aldrich), anti–β-actin (Sigma-Aldrich), 
anti-GAPDH (Millipore, Bedford, MA), anti-NCoR (ATGEN, Seong-
nam, Gyeonggido, Korea), anti–E-cadherin, anti–MMP-9 (Calbio-
chem), anti-vimentin (Santa Cruz Biotechnology, Santa Cruz, CA), 
anti-p300 (Upstate), anti–c-Jun (Epitomics, Burlingame, CA), anti–
acetyl-histone H3, anti-IP-10 (Santa Cruz Biotechnology), and anti-
Myc (Cell Signaling, Danvers, MA). The antibody against phospho-
Ser was from Zymed Laboratories (San Francisco, CA). The antibody 
against phospho-NCoR1 was raised against the synthetic peptide 
CQYETLpSDSDD by LabFrontier (Anyang, Gyeonggido, Korea). 
The antibodies against SMRT and HDAC3 were generated as de-
scribed previously (Li et al., 2000). Both CK2α and CK2β constructs 
were generated by PCR and cloned into the pSG5-KF2M1 and 
pSG5-KM2M1 (Sigma-Aldrich) plasmid vectors. The origins of pSG5-
Flag-NCoR-1/2 (1–380), pSG5-Flag-NCoR-9/10 (714–1053), pSG5-
Flag-NCoR-11/12 (1053–1476), pSG5-Flag-NCoR-13/14 (1487–
1949), and pSG5-Flag-NCoR-15/16 (1985–2440) were described 
previously (Li et al., 2000). Full-length pCMV-GFP-NCoR (1–2453) 
was previously described (Jonas and Privalsky, 2004). The FLAG-
tagged Siah1 was obtained from DNASU Plasmid Repository (Ari-
zona State University, Tempe, AZ).
Duolink in situ PLA analysis
Duolink in situ PLA analysis was performed according to the manu-
facturer’s instructions (OLink Biosciences, Uppsala, Sweden). Briefly, 
paraformaldehyde-fixed cells were washed with phosphate-buffered 
saline, incubated for 15 min in 1.5% hydrogen peroxide, washed, 
and blocked with blocking solution. Primary rabbit antibody was ap-
plied, and the cells were incubated with PLUS and MINUS second-
ary PLA probes against rabbit immunoglobulin G (IgG) only or 
against both rabbit and mouse IgGs. The incubation was followed 
by hybridization and ligation, and then amplification was performed. 
After being mounted with Duolink mounting medium, samples were 
examined using an Olympus FluoView FV1000 confocal microscope 
(Olympus, Tokyo, Japan).
ChIP assays
ChIP assays were performed with the indicated antibodies as de-
scribed previously (Yoon et al., 2003b), but without SDS in all buffers. 
Eluted DNA was amplified with specific primers using SYBR Green 
PCR Master Mix (Applied Biosystems, Foster City, CA). Primers used 
in PCR were as follows: P1 (forward [F]: 5′-CCAGGCATTGTTT-
GAACTGC-3′; reverse [R]: 5′-AGCAAAAGATGTCTTGCACAAA-3′). 
P2 (F: 5′-GACTACCTCTCTCTAGAACT-3′; R: 5′-GATCTCAACACGT-
GGACAAA-3′). All reactions were normalized relative to input activi-
ties and are presented as means (± SD) of three independent 
experiments.
siRNA experiments
The siRNAs against NCoR1 or CK2α, as well as a nonspecific siRNA, 
were obtained from GenePharma (Shanghai, China). For siRNA 
transfection, HeLa and HCE4 cells were incubated with DMEM 
without FBS and antibiotics for 12 h, and transfected with 200 nM 
nonspecific siRNA, siRNA-NcoR1, and siRNA-CK2 using Lipo-
fectamine 2000 following the manufacturer’s protocol (Invitrogen, 
Carlsbad, CA). After 4 h, the medium was changed, and cells were 
incubated for 2 d. siRNAs against NCoR1 and CK2α were designed 
as follows: siNCoR-1 (F: 5′-GGUGAUAAUACCAAAGAAATT-3′; 
R: 5′-UUUCUUUGGUAUUAUCACCTT-3′), siNCoR-2 (F: 5′-GGU-
GAUAAUACCAAAGAAATT-3′; R: 5′-UUUCUUUGGUAUUAUCAC-
CTT-3′), siNCoR-3 (F: 5′-GGCUCUCAAAGUUCAGACUTT-3′; R: 
5′-AGTCTGAACTTTGAGAGCCTT-3′), siSMRT (F: 5′-GUUCAACA-
CACUUGACAAATT-3′; R: 5′-UUUGUCAAGUGUGUUGGACTT-3′), 
siSnail1 (F: 5′-XTGCACATCCGAAGCCACAC-3′; R: 5′- GUGUGGC-
UUCGGAUGUGCATT-3′), siCK2 (F: 5′-CAGAAAGCUACGAC-
UAAUATT-3′; R: 5′-RUAUUAGUCGUAGCUUUCUGTG-3′), and sic-
Jun (F: 5′-GAGCGGACCUUAUGGCUACUU-3′; R: 5′- GUAGCCA-
UAAGGUCCGCUCUU-3′). The siRNA sequences against HDAC1, 
HDAC2, HDAC3, and HDAC8 were previously described (Kim et al., 
2010).
Real-time PCR analysis
Real-time PCR analysis and quantification were performed with SYBR 
Green PCR Master Mix reagents on an ABI Prism 7300 Sequence 
Detection System. The singularity and specificity of amplification 
were verified using 7300 System Software (ABI). All samples were 
normalized to human GAPDH. Primer sequences for amplification of 
IP-10 RNA were 5′-CTGCCATTCTGATTTGCTGC-3′ (F) and 5′-GAT-
GGCCTTCGATTCTGGAT-3′ (R). Primer sequences for amplification 
of E-cadherin RNA were 5′-AACGCATTGCCACATACACT-3′ (F) and 
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Chick CAM invasion assay
HCE4 cells were labeled with Fluoresbrite carboxylate nanospheres 
(Polysciences, Warrington, PA) and cultured on CAMs of 11-d-old 
chick embryos for 3 d. Invasion was monitored in cross-sections of 
the fixed CAMs by fluorescence microscopy.
Statistical analysis
Statistical analyses were done using Student’s t test with Bonferroni 
for multiple comparisons. p < 0.05 was considered significant.
5′-CCATGACAGACCCCTTAAAGA-3′ (R). Primer sequences for am-
plification of CXCL12 RNA were 5′-GGTCGTGCTGGTCCTCGT-3′ 
(F) and 5′-TTAGCTTCGGGTCAATGCAC-3′ (R). Primer sequences 
for amplification of DIO2 RNA were 5′-GCAGCTTCTGGAG-
CGTTTCT-3′ (F) and 5′-TGTCTCTGCACAATGCACACA-3′ (R). 
Primer sequences for amplification of IFIT1 RNA were 5′-ACTG-
GCAGAAGCCCAGACTT-3′ (F) and 5′-GCCCGTTCATAATTCTTT-
CCT-3′ (R). Primer sequences for amplification of TPM4 RNA were 
5′-GGACAGGGCTCAGGAACGA-3′ (F) and 5′-TTGAGCTGCATCT-
CCTGAATCT-3′ (R). All reactions were performed in triplicate. Rela-
tive expression levels and SDs were calculated using the compara-
tive method.
cDNA microarray analysis
HCE4 cells were transfected with 100 pmol of control siRNA, siCK2, 
or siNCoR. Biotinylated cRNA was obtained using a total RNA am-
plification kit (Ambion, Austin, TX) according to the manufacturer’s 
instructions. Briefly, 550 ng of total RNA was reverse-transcribed to 
cDNA using a T7 oligo (dT) primer. Second-strand cDNA was syn-
thesized, in vitro transcribed, and labeled with biotin-NTP. After pu-
rification, the cRNA was quantified using the ND-1000 Spectropho-
tometer (NanoDrop, Wilmington, DE). Labeled cRNA samples 
(750 ng) were hybridized to human-8 expression bead arrays for 
16–18 h at 58°C, according to the manufacturer’s instructions 
(Illumina, San Diego, CA). Detection of the array signal was per-
formed using Amersham fluorolink streptavidin-Cy3 (GE Healthcare 
Life Sciences, Little Chalfont, UK) according to the bead array man-
ual. Arrays were scanned with an Illumina bead array reader confo-
cal scanner according to the manufacturer’s instructions. Array data 
export processing and analysis were performed using Illumina 
GenomeStudio version 2009.2 (Gene Expression Module v1.5.4). 
Data outputs and the average intensity for each array from two inde-
pendent experiments were normalized against housekeeping genes 
located on each array. Differentially expressed genes were identi-
fied by comparison of the siCK2 sample set with the small-interfer-
ing control sample set, and the siNCoR sample set to the small-
interfering control sample set, using p < 0.05 as the significance 
cutoff. Only fold changes greater than 2.0 were considered.
In vitro kinase assay
GST-fusion proteins were incubated with 500 U of recombinant CK2α 
(ATGEN) in the presence of kinase reaction buffer (10 μl 5× kinase 
buffer, 10 μl magnesium/ATP cocktail solution 90 μl 75 mM 
MgCl2/500 mM ATP plus 10 μl [100 μCi] of [γ-32P]ATP [3000 Ci/mmol]) 
in a total volume of 50 μl for 30 min at 30°C. Reactions were termi-
nated by washing twice with 1× kinase buffer. Samples were resus-
pended in 15 μl 5× SDS sample loading buffer and boiled for 5 min. 
After electrophoresis, SDS polyacrylamide gels were stained with 
Coomassie blue and dried, and the phosphorylated products were 
visualized by autoradiography or quantified by phosphorimager 
analysis.
Matrigel invasion assays
In vitro cell invasiveness was determined by the ability of cells to 
transmigrate through a layer of extracellular matrix in BioCoat Matri-
gel invasion chambers (SPL Lifescience, Pocheon, Gyeonggido, Ko-
rea). Posttransfected cells (48 h) were trypsinized and seeded at a 
density of 2.0 × 104 per insert. After 24 h, noninvading cells were 
removed with cotton swabs. Invading cells were fixed with 100% 
methanol and stained with 1% crystal violet (Sigma-Aldrich) before 
enumeration under an inverted microscope. Data are expressed as 
the mean ± SD of at least three independent experiments.
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